These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 32664162)

  • 1. Effect of thyrotropin suppressive therapy on heart rate variability and QT dispersion in patients with differentiated thyroid cancer.
    Liu C; Lv H; Li Q; Fu S; Tan J; Wang C; Wang X; Ma Y
    Medicine (Baltimore); 2020 Jul; 99(28):e21190. PubMed ID: 32664162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heart rate variability and QT dispersion in patients with subclinical hypothyroidism.
    Galetta F; Franzoni F; Fallahi P; Rossi M; Carpi A; Rubello D; Antonelli A; Santoro G
    Biomed Pharmacother; 2006 Sep; 60(8):425-30. PubMed ID: 16930934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sympatho-vagal control of heart rate variability in patients treated with suppressive doses of L-thyroxine for thyroid cancer.
    Casu M; Cappi C; Patrone V; Repetto E; Giusti M; Minuto F; Murialdo G
    Eur J Endocrinol; 2005 Jun; 152(6):819-24. PubMed ID: 15941920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do Different TSH Suppression Levels Effect Heart Rate Variability and QT Dispersions in Patients with Differentiated Thyroid Cancer?
    Çelik S; Uç ZA; Candan Ö
    Endocr Res; 2024 Jul; ():1-8. PubMed ID: 39051971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of recombinant human thyrotropin on heart rate variability and blood pressure in patients on l-thyroxine-suppressive therapy for differentiated thyroid carcinoma.
    Murialdo G; Casu M; Cappi C; Patrone V; Repetto E; Copello F; Minuto F; Giusti M
    Horm Res; 2005; 64(2):100-6. PubMed ID: 16179790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of short-term metformin therapy associated with levothyroxine dose decrement on TSH and thyroid hormone levels in patients with thyroid cancer.
    Mousavi Z; Dourandish L; Rokni H; Sadeghi R; Rasoul Zakavi S
    Minerva Endocrinol; 2014 Mar; 39(1):59-65. PubMed ID: 24513605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefits of thyrotropin suppression versus the risks of adverse effects in differentiated thyroid cancer.
    Biondi B; Cooper DS
    Thyroid; 2010 Feb; 20(2):135-46. PubMed ID: 20151821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of percutaneous transluminal coronary angioplasty on QT dispersion and heart rate variability parameters.
    Aydinlar A; Sentürk T; Ozdemïr B; Kaderlï AA; Aydin O
    Cardiovasc J Afr; 2009; 20(4):240-4. PubMed ID: 19701536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of carvedilol therapy on arrhythmia markers in patients with congestive heart failure.
    Akdeniz B; Guneri S; Savas IZ; Aslan O; Baris N; Badak O; Kirimli O; Göldeli O
    Int Heart J; 2006 Jul; 47(4):565-73. PubMed ID: 16960411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone mineral density in women receiving thyroxine suppressive therapy for differentiated thyroid carcinoma.
    Chen CH; Chen JF; Yang BY; Liu RT; Tung SC; Chien WY; Lu YC; Kuo MC; Hsieh CJ; Wang PW
    J Formos Med Assoc; 2004 Jun; 103(6):442-7. PubMed ID: 15278189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in heart rate variability and QT dispersion in patients with overt hypothyroidism.
    Galetta F; Franzoni F; Fallahi P; Tocchini L; Braccini L; Santoro G; Antonelli A
    Eur J Endocrinol; 2008 Jan; 158(1):85-90. PubMed ID: 18166821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical inertia in thyrotropin suppressive therapy for low-risk differentiated thyroid cancer: A real-world experience at an endocrine center in Bangkok.
    Thewjitcharoen Y; Chatchomchuan W; Wanothayaroj E; Butadej S; Nakasatien S; Krittiyawong S; Rajatanavin R; Himathongkam T
    Medicine (Baltimore); 2024 May; 103(21):e38290. PubMed ID: 38788029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Chronic Suppression or Oversuppression of Thyroid-Stimulating Hormone on Psychological Symptoms and Sleep Quality in Patients with Differentiated Thyroid Cancer.
    Altuntaş SÇ; Hocaoğlu Ç
    Horm Metab Res; 2021 Oct; 53(10):683-691. PubMed ID: 34607367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes within the thyroid axis after long-term TSH-suppressive levothyroxine therapy.
    Verburg FA; Smit JW; Grelle I; Visser TJ; Peeters RP; Reiners C
    Clin Endocrinol (Oxf); 2012 Apr; 76(4):577-81. PubMed ID: 22017394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [L-thyroxine therapy in differentiated thyroid carcinoma: criteria for evaluation of TSH suppression].
    Kowalczyk P; Roskosz J; Jurecka-Tuleja B; Gubała E; Czernik E; Jarzab B
    Wiad Lek; 2001; 54(5-6):268-76. PubMed ID: 11556209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imbalance of cardiac autonomic nervous activity and increase of ventricular repolarization dynamicity induced by thyroid hormones in hyperthyroidism.
    Cai Z; Dai M; Zhang Y; Zhong H; Tan T; Bao M
    Auton Neurosci; 2018 Sep; 213():86-91. PubMed ID: 30005745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trabecular bone deterioration in differentiated thyroid cancer: Impact of long-term TSH suppressive therapy.
    Hawkins Carranza F; Guadalix Iglesias S; Luisa De Mingo Domínguez M; Martín-Arriscado Arroba C; López Álvarez B; Allo Miguel G; Martínez Díaz-Guerra G
    Cancer Med; 2020 Aug; 9(16):5746-5755. PubMed ID: 32583973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Research of relationship between thyroid-stimulating hormone level after surgery and hypercholesterolemia in female patients with differentiated thyroid cancer].
    Zhang B; Geng L; Lin H; Jia Q; Li T
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Jun; 34(6):554-557. PubMed ID: 32842190
    [No Abstract]   [Full Text] [Related]  

  • 19. Free thyroxine, free triiodothyronine, and thyrotropin concentrations in hypothyroid and thyroid carcinoma patients receiving thyroxine therapy.
    Liewendahl K; Helenius T; Lamberg BA; Mähönen H; Wägar G
    Acta Endocrinol (Copenh); 1987 Nov; 116(3):418-24. PubMed ID: 3687325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body Composition, Resting Energy Expenditure, and Metabolic Changes in Women Diagnosed with Differentiated Thyroid Carcinoma.
    Izkhakov E; Vaisman N; Barnes S; Barchana M; Stern N; Keinan-Boker L
    Thyroid; 2019 Aug; 29(8):1044-1051. PubMed ID: 31088334
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.